Anthony Reichelderfer

Anthony Reichelderfer is a Senior Research Associate at Prelude Therapeutics, with a solid background in scientific research and laboratory operation. Prior to joining Prelude Therapeutics in November 2022, Anthony served as a Staff Scientist II at ChristianaCare, where responsibilities included maintaining mammalian cell lines and executing CRISPR directed gene editing for cancer therapeutics, achieving a promotion within one year. Anthony's earlier experience includes roles as an Associate Scientist at QPS Holdings, LLC, involving cell-based assays, and positions at GlaxoSmithKline Pharma GmbH and SRG Woolf Group, focusing on vaccine filling and aseptic processes. Anthony holds a Bachelor's degree in Biology and a minor in Chemistry from Millersville University of Pennsylvania.